Man Group PLC Ligand Pharmaceuticals Inc Transaction History

Man Group PLC

$36 Billion
Q3 2024

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	SELL	$68.64 - $89.2 $5.2 Million - $6.76 Million	-75,780 Reduced 52.47%	68,657 $5.02 Million
Q4 2023 Feb 14, 2024	SELL	$49.57 - $72.63 $142,216 - $208,375	-2,869 Reduced 1.95%	144,437 $10.3 Million
Q3 2023 Nov 14, 2023	BUY	$58.86 - $72.67 $67,453 - $83,279	1,146 Added 0.78%	147,306 $8.83 Million
Q2 2023 Aug 14, 2023	BUY	$69.53 - $79.33 $604,354 - $689,536	8,692 Added 6.32%	146,160 $10.5 Million
Q1 2023 May 15, 2023	BUY	$65.67 - $77.08 $1.6 Million - $1.88 Million	24,389 Added 21.57%	137,468 $10.1 Million
Q4 2022 Feb 14, 2023	BUY	$61.72 - $96.74 $696,139 - $1.09 Million	11,279 Added 11.08%	113,079 $7.55 Million
Q3 2022 Nov 14, 2022	BUY	$0.01 - $107.56 $447 - $4.81 Million	44,700 Added 78.28%	101,800 $8.77 Million
Q2 2022 Aug 15, 2022	BUY	$74.52 - $117.06 $4.26 Million - $6.68 Million	57,100 New	57,100 $5.09 Million
Q2 2021 Aug 16, 2021	SELL	$113.03 - $155.64 $377,859 - $520,304	-3,343 Closed	0 $0
Q1 2021 May 17, 2021	SELL	$99.52 - $215.83 $5.92 Million - $12.8 Million	-59,522 Reduced 94.68%	3,343 $510,000
Q4 2020 Feb 16, 2021	SELL	$80.55 - $106.05 $4.31 Million - $5.67 Million	-53,484 Reduced 45.97%	62,865 $6.25 Million
Q3 2020 Nov 16, 2020	BUY	$89.56 - $126.72 $6.57 Million - $9.3 Million	73,371 Added 170.72%	116,349 $11.1 Million
Q2 2020 Aug 14, 2020	BUY	$68.28 - $123.65 $552,112 - $999,833	8,086 Added 23.17%	42,978 $4.81 Million
Q1 2020 May 15, 2020	SELL	$63.37 - $107.88 $7.98 Million - $13.6 Million	-125,955 Reduced 78.31%	34,892 $2.54 Million
Q4 2019 Feb 18, 2020	BUY	$96.94 - $113.59 $5.49 Million - $6.43 Million	56,598 Added 54.29%	160,847 $16.8 Million
Q3 2019 Nov 14, 2019	SELL	$86.25 - $120.16 $775,991 - $1.08 Million	-8,997 Reduced 7.94%	104,249 $10.4 Million
Q2 2019 Aug 14, 2019	BUY	$107.38 - $129.34 $7.72 Million - $9.3 Million	71,892 Added 173.85%	113,246 $12.9 Million
Q1 2019 May 15, 2019	SELL	$105.93 - $142.47 $3.07 Million - $4.14 Million	-29,028 Reduced 41.24%	41,354 $5.2 Million
Q4 2018 Feb 14, 2019	SELL	$128.36 - $272.13 $688,009 - $1.46 Million	-5,360 Reduced 7.08%	70,382 $9.55 Million
Q3 2018 Nov 14, 2018	SELL	$211.18 - $274.49 $9.33 Million - $12.1 Million	-44,166 Reduced 36.83%	75,742 $20.8 Million
Q2 2018 Aug 14, 2018	SELL	$150.77 - $207.98 $6.68 Million - $9.21 Million	-44,292 Reduced 26.97%	119,908 $24.8 Million
Q1 2018 May 15, 2018	BUY	$138.63 - $182.62 $22.8 Million - $30 Million	164,200 New	164,200 $27.1 Million

Others Institutions Holding LGND

# of Institutions

257

Shares Held

18.2M

Call Options Held

26.8K

Put Options Held

9.3K

View Full List

About LIGAND PHARMACEUTICALS INC

Ticker LGND
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 16,882,800
Market Cap $2.01B
Description
Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, focuses on developing or acquiring technologies that help pharmaceutical companies to discover and develop medicines worldwide. Its commercial programs include Kyprolis and Evomela, which are used to treat multiple myeloma; Veklury for the treatment of moderate or severe COVID-19;...

More about LGND

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Man Group PLC, based on Form 13F filings with the SEC.

News

Stay updated on Man Group PLC with notifications on news.

Account